Nucleus RadioPharma specializes in providing comprehensive contract development and manufacturing organization (CDMO) services tailored for targeted radiotherapies. The company focuses on building robust clinical and commercial supply chains to support radiopharmaceutical companies in bringing life-saving therapies to market. With a strong emphasis on scientific expertise, Nucleus RadioPharma leverages over 150 years of collective experience in manufacturing and 250 years in radiopharmaceutical supply chain management. Their facilities, including a new site in Rochester, MN, are designed to support clients throughout the entire radiotherapy lifecycle, from pre-clinical to commercial stages, ensuring that production meets the unique demands of radioactive isotope-based products.

The company adopts a flexible approach to development and production, allowing them to cater to diverse client needs at any stage of the drug development process. Nucleus RadioPharma offers services that include establishing radiolabeling procedures, ensuring regulatory compliance, and managing clinical trial manufacturing. Their strategic positioning near key medical centers and distribution hubs enhances their ability to deliver radiotherapies efficiently, addressing the critical time constraints associated with radioactive isotopes. By focusing on quality assurance and regulatory guidance, Nucleus RadioPharma aims to accelerate the path to commercialization while maintaining high safety and quality standards, ultimately increasing patient access to innovative cancer treatments.

United States

Nucleus RadioPharma is a full-service Contract Development and Manufacturing Organization (CDMO) dedicated to building robust and reliable clinical and commercial supply chains for targeted radiotherapies.

Nucleus RadioPharma

Company Details